Slideshare uses cookies to improve functionality and performance, and to provide you with relevant advertising. If you continue browsing the site, you agree to the use of cookies on this website. See our User Agreement and Privacy Policy.
Slideshare uses cookies to improve functionality and performance, and to provide you with relevant advertising. If you continue browsing the site, you agree to the use of cookies on this website. See our Privacy Policy and User Agreement for details.
Scribd will begin operating the SlideShare business on December 1, 2020 As of this date, Scribd will manage your SlideShare account and any content you may have on SlideShare, and Scribd's General Terms of Use and Privacy Policy will apply. If you wish to opt out, please close your SlideShare account. Learn more.
Published on
Today, a mix of influences - including innovation in biology and technology, market demand and consumerism - is furthering a genomic medicine evolution that crosses industries.
To benefit from the far-reaching industry transformation that has begun, forward-thinking executives can: verify that genomic medicine is part of their enterprise vision and strategy; assess and plan to fill existing and future skill gaps; and look closely at how and when partnering will help their organizations succeed in meeting stakeholder needs.
Be the first to comment